Furthermore, PAK4 overexpression has been detected in thyroid cancer, cell lines derived from breast, prostate, gall bladder, stomach and ovarian cancers, as well as in several primary tumors [20–25]. This evidence concerns the gene PAK4 and thyroid cancer.